Report cover image

Neuromodulation Market Size, Share & Trends Analysis Report By Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Transcranial Magnetic Stimulators, Other), By Technology (Internal, External), By A

Publisher Straits Research
Published Nov 28, 2024
SKU # STRA19656130

Description

Neuromodulation Market Analysis and Insights

The Neuromodulation Market size is anticipated to reach USD 4.38 billion in 2023 and it is projected to reach USD 9.96 billion by 2032, growing at a CAGR of 9.9% during the forecast period.

The Global Neuromodulation Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis.

The Global Neuromodulation Market growth, Size report provides a comprehensive analysis of the Medical Devices industry, analyzes and identifies changes in market conditions set to impact future business decisions by analyzing.

Research Methodology

Our research methodology constitutes a mix of secondary & primary research which ideally starts from exhaustive data mining, conducting primary interviews (suppliers/distributors/end-users), and formulating insights, estimates, growth rates accordingly. Final primary validation is a mandate to confirm our research findings with Key Opinion Leaders (KoLs), Industry Experts, Neuromodulation Market includes major supplies & Independent Consultants among others.

Global Market Scope and Neuromodulation Market

The scope of the report is to provide a 360-degree view of the market outlook by assessing the entire value chain and analyzing the key Neuromodulation Market trends from 2024 to 2032 underlying in specific geographies. Qualitative and quantitative aspects are interlinked to provide rationales on market numbers, CAGR, and forecasts.

Neuromodulation Market Country Level Analysis

The Global Neuromodulation Market Industry Analysis Research Report provides a basic overview of industry dominating market share expected 2024 to 2032. A detailed section on Neuromodulation Market share and status of critical industries is included in the report, covering. Market Segment by Regions (North America, Europe, Asia Pacific, South America and The Middle East and Africa), coverage with region wise data from 2024 to 2032.

Top Players in Neuromodulation Market

Some of the other major highlights of the demand for Neuromodulation Market include analysis, purchasing volume, prices, pricing analysis, and regulatory framework. Coverage on manufacturing structure, distribution channels, and Porter’s Five Forces analysis are also incorporated in the scope to provide analysis on the demand and supply side. This is anticipated to create opportunities for the growth of the Neuromodulation Market during the forecast period.
  • Medtronic plc
  • LivaNova PLC
  • NeuroPace, Inc.
  • Axonics Modulation Technologies, Inc.
  • Bioventus LLC
  • Neuronetics, Inc.
  • Cochlear Ltd.

Market Segmentation

The Global Neuromodulation Market Share, Demand provides the most up-to-date Medical Devices industry data on the actual market situation, size, trends and future outlook. The research includes historic data from 2021 to 2023 and forecasts until 2032.

Neuromodulation Market Segmentation
  • By Product
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Transcranial Magnetic Stimulators
    • Other
  • By Technology
    • Internal
    • External
  • By Application
    • Parkinson’s Disease
    • Chronic Pain
    • Migraine
    • Epilepsy
    • Tremor
    • Depression
    • Urinary and Faecal Incontinence
    • Others
  • By Biomaterial
    • Polymeric Biomaterial
    • Metallic Biomaterial
    • Ceramic Biomaterial
  • By End-User
    • Hospitals and Ambulatory Surgery Centers (ASC)
    • Clinics and Physiotherapy Centers
    • Others

Regions Coverd
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Nordic
    • Benelux
    • Rest of Europe
  • APAC
    • China
    • Korea
    • Japan
    • India
    • Australia
    • Singapore
    • Taiwan
    • South East Asia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • UAE
    • Turkey
    • Saudi Arabia
    • South Africa
    • Egypt
    • Nigeria
    • Rest of MEA
  • LATAM
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Rest of LATAM

Reasons for Doing the Study:

This report is an update of an earlier (2023) Research study. Since the previous edition of this report was published, the Public Safety and Security market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.

Table of Contents

1 Executive Summary
2 Research Scope & Segmentation
2.1 Research Objectives
2.2 Limitations & Assumptions
2.3 Market Scope & Segmentation
2.4 Currency & Pricing Considered
3 Market Opportunity Assessment
3.1 Emerging Regions / Countries
3.2 Emerging Companies
3.3 Emerging Applications / End Use
4 Market Trends
4.1 Drivers
4.2 Market Warning Factors
4.3 Latest Macro Economic Indicators
4.4 Geopolitical Impact
4.5 Technology Factors
5 Market Assessment
5.1 Porters Five Forces Analysis
5.2 Value Chain Analysis
6 Global Neuromodulation Market Size Analysis
6.1 By Product (2020-2032)
6.1.1 Spinal Cord Stimulators
6.1.2 Deep Brain Stimulators
6.1.3 Sacral Nerve Stimulators
6.1.4 Vagus Nerve Stimulators
6.1.5 Transcranial Magnetic Stimulators
6.1.6 Other
6.2 By Technology (2020-2032)
6.2.1 Internal
6.2.2 External
6.3 By Application (2020-2032)
6.3.1 Parkinson’s Disease
6.3.2 Chronic Pain
6.3.3 Migraine
6.3.4 Epilepsy
6.3.5 Tremor
6.3.6 Depression
6.3.7 Urinary and Faecal Incontinence
6.3.8 Others
6.4 By Biomaterial (2020-2032)
6.4.1 Polymeric Biomaterial
6.4.2 Metallic Biomaterial
6.4.3 Ceramic Biomaterial
6.5 By End-User (2020-2032)
6.5.1 Hospitals and Ambulatory Surgery Centers (ASC)
6.5.2 Clinics and Physiotherapy Centers
6.5.3 Others
7 North America Market Analysis
7.1 By Product (2020-2032)
7.1.1 Spinal Cord Stimulators
7.1.2 Deep Brain Stimulators
7.1.3 Sacral Nerve Stimulators
7.1.4 Vagus Nerve Stimulators
7.1.5 Transcranial Magnetic Stimulators
7.1.6 Other
7.2 By Technology (2020-2032)
7.2.1 Internal
7.2.2 External
7.3 By Application (2020-2032)
7.3.1 Parkinson’s Disease
7.3.2 Chronic Pain
7.3.3 Migraine
7.3.4 Epilepsy
7.3.5 Tremor
7.3.6 Depression
7.3.7 Urinary and Faecal Incontinence
7.3.8 Others
7.4 By Biomaterial (2020-2032)
7.4.1 Polymeric Biomaterial
7.4.2 Metallic Biomaterial
7.4.3 Ceramic Biomaterial
7.5 By End-User (2020-2032)
7.5.1 Hospitals and Ambulatory Surgery Centers (ASC)
7.5.2 Clinics and Physiotherapy Centers
7.5.3 Others
7.5 U.S.
7.6 Canada
8 Europe Market Analysis
8.1 By Product (2020-2032)
8.1.1 Spinal Cord Stimulators
8.1.2 Deep Brain Stimulators
8.1.3 Sacral Nerve Stimulators
8.1.4 Vagus Nerve Stimulators
8.1.5 Transcranial Magnetic Stimulators
8.1.6 Other
8.2 By Technology (2020-2032)
8.2.1 Internal
8.2.2 External
8.3 By Application (2020-2032)
8.3.1 Parkinson’s Disease
8.3.2 Chronic Pain
8.3.3 Migraine
8.3.4 Epilepsy
8.3.5 Tremor
8.3.6 Depression
8.3.7 Urinary and Faecal Incontinence
8.3.8 Others
8.4 By Biomaterial (2020-2032)
8.4.1 Polymeric Biomaterial
8.4.2 Metallic Biomaterial
8.4.3 Ceramic Biomaterial
8.5 By End-User (2020-2032)
8.5.1 Hospitals and Ambulatory Surgery Centers (ASC)
8.5.2 Clinics and Physiotherapy Centers
8.5.3 Others
8.5 U.K.
8.6 Germany
8.7 France
8.8 Spain
8.9 Italy
8.10 Russia
8.11 Nordic
8.12 Benelux
8.13 Rest of Europe
9 APAC Market Analysis
9.1 By Product (2020-2032)
9.1.1 Spinal Cord Stimulators
9.1.2 Deep Brain Stimulators
9.1.3 Sacral Nerve Stimulators
9.1.4 Vagus Nerve Stimulators
9.1.5 Transcranial Magnetic Stimulators
9.1.6 Other
9.2 By Technology (2020-2032)
9.2.1 Internal
9.2.2 External
9.3 By Application (2020-2032)
9.3.1 Parkinson’s Disease
9.3.2 Chronic Pain
9.3.3 Migraine
9.3.4 Epilepsy
9.3.5 Tremor
9.3.6 Depression
9.3.7 Urinary and Faecal Incontinence
9.3.8 Others
9.4 By Biomaterial (2020-2032)
9.4.1 Polymeric Biomaterial
9.4.2 Metallic Biomaterial
9.4.3 Ceramic Biomaterial
9.5 By End-User (2020-2032)
9.5.1 Hospitals and Ambulatory Surgery Centers (ASC)
9.5.2 Clinics and Physiotherapy Centers
9.5.3 Others
9.5 China
9.6 Korea
9.7 Japan
9.8 India
9.9 Australia
9.10 Singapore
9.11 Taiwan
9.12 South East Asia
9.13 Rest of Asia-Pacific
10 Middle East and Africa Market Analysis
10.1 By Product (2020-2032)
10.1.1 Spinal Cord Stimulators
10.1.2 Deep Brain Stimulators
10.1.3 Sacral Nerve Stimulators
10.1.4 Vagus Nerve Stimulators
10.1.5 Transcranial Magnetic Stimulators
10.1.6 Other
10.2 By Technology (2020-2032)
10.2.1 Internal
10.2.2 External
10.3 By Application (2020-2032)
10.3.1 Parkinson’s Disease
10.3.2 Chronic Pain
10.3.3 Migraine
10.3.4 Epilepsy
10.3.5 Tremor
10.3.6 Depression
10.3.7 Urinary and Faecal Incontinence
10.3.8 Others
10.4 By Biomaterial (2020-2032)
10.4.1 Polymeric Biomaterial
10.4.2 Metallic Biomaterial
10.4.3 Ceramic Biomaterial
10.5 By End-User (2020-2032)
10.5.1 Hospitals and Ambulatory Surgery Centers (ASC)
10.5.2 Clinics and Physiotherapy Centers
10.5.3 Others
10.5 UAE
10.6 Turkey
10.7 Saudi Arabia
10.8 South Africa
10.9 Egypt
10.10 Nigeria
10.11 Rest of MEA
11 LATAM Market Analysis
11.1 By Product (2020-2032)
11.1.1 Spinal Cord Stimulators
11.1.2 Deep Brain Stimulators
11.1.3 Sacral Nerve Stimulators
11.1.4 Vagus Nerve Stimulators
11.1.5 Transcranial Magnetic Stimulators
11.1.6 Other
11.2 By Technology (2020-2032)
11.2.1 Internal
11.2.2 External
11.3 By Application (2020-2032)
11.3.1 Parkinson’s Disease
11.3.2 Chronic Pain
11.3.3 Migraine
11.3.4 Epilepsy
11.3.5 Tremor
11.3.6 Depression
11.3.7 Urinary and Faecal Incontinence
11.3.8 Others
11.4 By Biomaterial (2020-2032)
11.4.1 Polymeric Biomaterial
11.4.2 Metallic Biomaterial
11.4.3 Ceramic Biomaterial
11.5 By End-User (2020-2032)
11.5.1 Hospitals and Ambulatory Surgery Centers (ASC)
11.5.2 Clinics and Physiotherapy Centers
11.5.3 Others
11.5 Brazil
11.6 Mexico
11.7 Argentina
11.8 Chile
11.9 Colombia
11.10 Rest of LATAM
12 Competitive Landscape
12.1 Global Neuromodulation Market Share By Players
12.2 M & A Agreements & Collaboration Analysis
13 Market Players Assessment
13.1 American International Industries (GIGI)
13.1.1 Overview
13.1.2 Business Information
13.1.3 Revenue
13.1.4 ASP
13.1.5 Swot Analysis
13.1.6 Recent Developments
13.2 Boston Scientific Corporation
13.3 Abbott Laboratories
13.4 Nevro Corporation
13.5 LivaNova PLC
13.6 NeuroPace, Inc.
13.7 Axonics Modulation Technologies, Inc.
13.8 Bioventus LLC
13.9 Neuronetics, Inc.
13.10 Cochlear Ltd.
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.1.1 Major secondary sources
14.1.1.2 Key data from secondary sources
14.1.2 Primary Data
14.1.2.1 Key data from primary sources
14.1.2.2 Breakdown of primaries
14.1.3 Secondary And Primary Research
14.1.3.1 Key industry insights
14.2 Market Size Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach
14.2.3 Market Projection
14.3 Research Assumptions
14.3.1 Assumptions
14.4 Limitations
14.5 Risk Assessment
15 Appendix
15.1 Discussion Guide
15.2 Customization Options
15.3 Related Reports
16 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us